Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.8 (
cholinesterase
)
12,691
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Inositol monophosphatase
(
IMPase
), a cytoplasmic enzyme that hydrolyses inositol monophosphates to produce inositol is also found in the cerebrospinal fluid (CSF). Since levels of inositol have been previously reported to be elevated in Down syndrome (DS) CSF,
IMPase
activity was measured in CSF of DS subjects to establish whether altered inositol levels may be related to changes in
IMPase
activity. In addition, and to better understand the regulation of
IMPase
expression in the CSF, enzyme activity was measured in normal aging, patients with Alzheimer-type or multi-infarct dementia (DAT and MID, respectively) and in CSF obtained by repeat lumbar puncture or from sequential aliquots of CSF from along the rostro-caudal axis.
IMPase
activity was relatively constant in CSF obtained from repeated lumbar puncture and there was no significant rostro-caudal gradient of activity in either normal or DS subjects, indicating that the enzyme originates from both brain and spinal cord. Compared to respective age-matched normal subjects, CSF
IMPase
activity was unaltered in DS, DAT and MID. However, in normal volunteers there was a significant positive correlation between age and CSF
IMPase
activity. Furthermore, there were significant correlations between CSF
IMPase
activity and acetylcholinesterase and
butyrylcholinesterase
activities and total protein, suggesting co-regulation of these parameters within the CSF.
...
PMID:Inositol monophosphatase activity in normal, Down syndrome and dementia of the Alzheimer type CSF. 1195 1